Business Development Executive at Singular Genomics

South East, South East, Botswana

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, GenomicsIndustries

Requirements

5–10+ years of experience in life science tools, genomics, or molecular diagnostics sales
Proven success in closing high-value deals with pharma, biotech, or academic medical centers
Strong technical acumen in genomics, spatial biology, or single-cell analysis
Excellent communication, negotiation, and executive presence
Ability to travel 30–50%
Bachelor’s degree in Life Sciences; advanced degree (MS, PhD, MBA) a plus
Preferred Qualifications
Experience selling novel platforms or disruptive life science technologies
Established network across East Coast translational and clinical research sites
Familiarity with spatial transcriptomics, immuno-oncology, or biomarker discovery markets

Responsibilities

Identify, develop, and close new business opportunities in the Midwest territory
Build and manage relationships with key stakeholders in biopharma, academic centers, CROs, and research hospitals
Navigate complex sales cycles involving scientific, technical, and procurement stakeholders
Deliver compelling value propositions aligned to customer workflows and research priorities
Manage forecasting, territory planning, and CRM tracking
Collaborate with Field Applications, Marketing, and Executive teams to drive strategic deals and early access deployments
Represent the company at key regional meetings, trade shows, and networking events

Skills

Business Development

Sales

Customer Acquisition

Account Management

Quota Carrying

Genomics

Spatial Multiomics

Commercial Expansion

Singular Genomics

Biotechnology company advancing genomic sequencing

About Singular Genomics

Singular Genomics focuses on advancing the field of genomics, which involves studying the complete set of DNA in organisms. The company provides tools and technologies for genomic sequencing, helping clients like academic researchers, pharmaceutical companies, and clinical laboratories conduct multiomic research. This type of research examines various biological data, including DNA, RNA, and proteins, to gain insights into complex biological systems and diseases. Singular Genomics' main product is the G4 sequencing platform, which allows for ultra-high throughput and high-resolution spatial sequencing, enabling researchers to process multiple samples at once. This efficiency sets Singular Genomics apart from competitors in the genomics market. The company's goal is to support scientific and medical research by offering high-performance sequencing technologies that aid in understanding and treating complex diseases.

San Diego, CaliforniaHeadquarters

2016Year Founded

$44.3MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Risks

Integration challenges post-acquisition by Deerfield may disrupt Singular Genomics' operations.

Technological advancements in genomics may outpace Singular Genomics' current offerings.

Intensifying competition in the genomics market could erode Singular Genomics' market share.

Differentiation

Singular Genomics offers the G4 Integrated Solution for high-throughput genomic sequencing.

The PX Integrated Solution combines single cell analysis, spatial analysis, and proteomics.

Singular Genomics' platforms emphasize accuracy, speed, flexibility, and scalability in sequencing.

Upsides

The acquisition by Deerfield Management offers a 254% premium, enhancing shareholder value.

Partnerships with companies like Fluent Biosciences expand Singular Genomics' product capabilities.

The rise of personalized medicine increases demand for Singular Genomics' multiomics solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free